The bioerodible sustained release implant technology was originally developed for ophthalmology, but the company believes it could have broader applications, such as for orthopedics.
Read the release about the partnership between pSivida and Hospital for Special Surgery.
Related Articles on Hospital for Special Surgery:
6 Ways to Build a Top Orthopedic Hospital department From Hospital for Special Srurgery's Dr. Thomas Sculco
Hospital for Special Surgery Creates Musculoskeletal Outcomes and Research Center
Hospital for Special Surgery Researchers: Obesity Decreases Risk of Respiratory Insufficiency
Hospital for Special Surgery to Test pSivida Technology in OrthopedicsWritten by Laura Miller | August 18, 2011
Hospital for Special Surgery in New York City and drug delivery company pSivida have entered into an agreement to jointly investigate the application of pSivida's drug delivery technology in orthopedics, according to a pSivida news release.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.